Evidence map›Paper›PMID 11791173›Full record

ArticleOncogene2002

Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.

Takeshi Nakamura, Misako Komiya, Noriko Gotoh, Shinichi Koizumi, Masabumi Shibuya, Nozomu Mori

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Takeshi NakamuraDepartment of Molecular Genetics, National Institute for Longevity Sciences, Oobu, Aichi 474-8522, Japan.
Misako Komiya
Noriko Gotoh
Shinichi Koizumi
Masabumi Shibuya
Nozomu Mori
Sumitomo Electric Industries (Japan) · JPTakarazuka City Hospital · JPThe University of Tokyo · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phosphotyrosine (pTyr) adapter Shc/ShcA is a major connector in various tyrosine kinase signalings following a variety of stimulation such as growth factor/neurotrophin, as well as in those following calcium influx and integrin activation. As in other tissues, Shc has been implicated in neuronal signalings; however, recent evidence suggests that N-Shc/ShcC and Sck/ShcB would take over most of the roles of Shc in mature central neurons, and switching phenomena between Shc and N-Shc expression were observed in several neuronal paradigms. Little is, however, known as to the signal-output differences between Shc and N-Shc. Here we determined the efficacy of Shc and N-Shc toward Erk activation in NGF-treated PC12 cells, and found that N-Shc transduced Grb2/Sos/Ras-dependent Erk activation less efficiently than Shc. This was mainly because N-Shc has only one high-affinity Grb2-binding site, whereas Shc has two such sites. Phosphopeptide mapping revealed that N-Shc has novel tyrosine-phosphorylation sites at Y259/Y260 and Y286; in vivo-phosphorylation of these tyrosines was demonstrated by site-specific anti-pTyr antibodies. Phosphorylated Y286 bound to several proteins, of which one was Crk. The pY221/pY222 site, corresponding to one of the Grb2-binding sites of Shc, also preferentially bound to Crk. The phosphorylation-dependent interaction between N-Shc and Crk was demonstrated in vitro and in vivo. These results indicate that N-Shc has specific features of signal-output, and further suggest that the switching between Shc and N-Shc during neural development and regeneration would lead to differentiation of downstream signalings.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportProto-Oncogene ProteinsAmino Acid SequenceAmino Acid SubstitutionAnimalsBinding SitesEnzyme ActivationGRB2 Adaptor ProteinMacromolecular SubstancesMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesMolecular Sequence DataNeoplasm ProteinsAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportCrk protein, ratGRB2 Adaptor ProteinGrb2 protein, ratMacromolecular SubstancesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesNeoplasm ProteinsNerve Growth FactorsNeuropeptidesPhosphotyrosineProtein KinasesProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-crkRecombinant Fusion ProteinsShc1 protein, ratShc3 protein, ratShc Signaling Adaptor ProteinsSrc Homology 2 Domain-Containing, Transforming Protein 1Src Homology 2 Domain-Containing, Transforming Protein 3

Identifiers

PMID11791173
OpenAlexW2039861416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.